Fear of Covid-19 in patients with obesity and the influence on bariatric surgery rates

Introduction: In this study, we aimed to examine and compare the effect of fear of Covid-19 disease on the lives of obese individuals and the effect of this fear on bariatric surgery rates, and the state of fear and anxiety in operated individuals. Materials and Methods: A total of 568 eligible patients were recruited for the study. The patients were screened for age, sex, body mass index (BMI), having bariatric surgery history, comorbidities and Covid-19 symptoms and diagnosis. The patients were evaluated for fear of Covid-19 with the Fear of Covid-19 Scale (FCV-19S). Results: A total of 568 patients were included in this study. The mean age of the female patients was 49. 71 ± 12.35. The mean age of the male patients was 40.38 ± 9.38. Of the patients, 208 (36.6%) were male, while 360 (63.4%) were female. There were significantly more patients with a bariatric surgery history and at least one Covid-19 symptom were (39.3%) than patients with no bariatric surgery history (20.9%) (P < 0.05). Patients with a BMI lower than 50 kg/m2 had significantly higher FCV-19S scores (P < 0.05). Conclusion: The population with the highest BMI may show less fear of Covid-19, according to FCV-19S. This kind of behaviour (fear, anxiety, etc.) may be seen as an effect of disregard. Obese populations should be treated by psychiatrists and should be educated about obesity and Covid-19.

Fear; Coronavirus; Covid-19; Bariatric surgery; Fear scale; Obesity

[1] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Journal of the American Medical Association. 2020; 323: 1061-1069.

[2] Lin CY. Social reaction toward the 2019 novel coronavirus (Covid-19). Social Health and Behavior. 2020; 3: 1-2.

[3] Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of Covid-19 scale: development and initial validation. International Journal of Mental Health and Addiction. 2020: 1-9.

[4] Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (Covid-19). Drug Discoveries & Therapeutics. 2020; 14: 58-60.

[5] Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. European Respiratory Journal. 2020; 55: 2000547.

[6] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395: 497-506.

[7] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020; 395: 507-513.

[8] Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Journal of the American Medical Association. 2020; 323: 1061-1069.

[9] Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese Medical Journal. 2020; 133: 1025-1031.

[10] Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. British Medical Journal. 2020; 368: m606.

[11] Fang L, Gao P, Bao H, Tang X, Wang B, Feng Y, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. The Lancet Respiratory Medicine. 2018; 6: 421-430.

[12] Duncan LA, Schaller M, Park JH. Perceived vulnerability to disease: de-velopment and validation of a 15-item self-report instrument. Personality and Individual Differences. 2009; 47: 541-546.

[13] Pappas G, Kiriaze IJ, Giannakis P, Falagas ME. Psychosocial conse-quences of infectious diseases. Clinical Microbiology and Infection. 2009; 15: 743-747.

[14] Ropeik D. The consequences of fear. EMBO Reports. 2004; 5: S56-S60.

[15] Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E. Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza. Infection Control & Hospital Epidemiology. 2010; 31: 676-682.

[16] Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. Journal of the American Medical Association. 2003; 289: 2801-2809.

[17] Garbati MA, Fagbo SF, Fang VJ, Skakni L, Joseph M, Wani TA, et al. A comparative study of clinical presentation and risk factors for adverse outcome in patients hospitalised with acute respiratory disease due to MERS coronavirus or other causes. PLoS One. 2016; 11: e0165978.

[18] Matsuyama R, Nishiura H, Kutsuna S, Hayakawa K, Ohmagari N. Clinical determinants of the severity of middle east respiratory syndrome (MERS): a systematic review and meta-analysis. BMC Public Health. 2016; 16: 1203.

[19] WHO. Clinical management of severe acute respiratory infection when novel coronavirus(nCoV) infection is suspected: interim guidance. 2020; Available at: https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected.

[20] Mitchell NS, Catenacci VA, Wyatt HR, Hill JO. Obesity: overview of an epidemic. Psychiatric Clinics of North America. 2011; 34: 717-732.

[21] Cotter EW, Kelly NR. Stress-related eating, mindfulness, and obesity. Health Psychology. 2018; 37: 516-525.

[22] Rundle AG, Park Y, Herbstman JB, Kinsey EW, Wang YC. Covid-19-related school closings and risk of weight gain among children. Obesity (Silver Spring). 2020; 28: 1008-1009.

[23] Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with Covid-19 in the Bronx, New York. Metabolism. 2020; 108: 154262.

[24] Chiappetta S, Sharma AM, Bottino V, Stier C. Covid-19 and the role of chronic inflammation in patients with obesity. International Journal of Obesity(London). 2020: 44:1790-1792.

[25] Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and Covid-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020: 43: 1392-1398.